Company page

Neuropace, Inc.

Neuropace, Inc. (Ticker: NPCE) is a public company based in America with a market capitalization of approximately $532.9 million. The company focuses on developing innovative solutions for neurological disorders. Neuropace aims to improve patient outcomes through its advanced medical technologies.

profileNPCE:NASDAQAI content: aiUpdated June 24, 2026/company/neuropace-inc/c-yopvxlj2
Neuropace, Inc. logo
Ticker
NPCE:NASDAQ
Asset type
Stock
Market cap
$532.9M
Sector
Health Technology
Industry
Medical Specialties
Exchange
NASDAQ
Currency
USD